期刊文献+

1型糖尿病酮症酸中毒脂代谢紊乱并发急性胰腺炎研究进展 被引量:2

原文传递
导出
摘要 胰岛素依赖型糖尿病又称为1型糖尿病(type 1 diabetes mellitus,T1DM),一般青少年时期起病[1-2]。病情严重或应激时易发生酮症酸中毒(diabetic ketoacidosis,DKA)。DKA是T1DM的急性代谢性并发症,据统计,每名已确诊的T1DM患者患DKA的风险可能高达10%[3-4]。DKA会导致碳水化合物、蛋白质、脂肪的代谢异常以及水电解质紊乱,引起严重的高甘油三酯血症(hypertriglyceridemia,HTG)[甘油三酯(triglyceride,TG)>1000 mg/dl],进而导致高甘油三酯血症性胰腺炎(HTG-induced pancreatitis,HTGP),严重者致命[3,5]。T1DM患者发生DKA时常合并血脂异常,主要表现为TG升高(即空腹血浆甘油三酯升高,超过同年龄和性别的第95百分位)、低密度脂蛋白(low density lipoprotein,LDL)升高、高密度脂蛋白(high density lipoprotein,HDL)降低[6]。
出处 《华南国防医学杂志》 CAS 2022年第2期154-158,F0003,共6页 Military Medical Journal of South China
基金 重庆市渝中区基础研究与前缘探索项目(20200101)。
  • 相关文献

参考文献2

二级参考文献13

  • 1[1]Feher M, Elkeles R.Lipid modification and coronary heart disease in type 2 diabetes:different from the general population.Heart,1999,81:10-11.
  • 2[2]Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III).JAMA,2001,285:2486-2497.
  • 3[3]Holman R. The UKPDS: implications for the dyslipidaemic patient. Acta Diabetol,2001,38: S9-14.
  • 4[4]Taskinen MR, Smith U. Lipid disorders in NIDDM: implications for treatment. Journal of Internal Medicine,1998,244:361-370.
  • 5[5]Barnett AH.Dyslipidaemia in diabetes-A GP guide.Practitioner,2002,246:120-123.
  • 6[6]Betteridge, DJ. Diabetic dyslipidaemia. Diabetes Obes Metab,2000,2:S31-36.
  • 7[7]Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med,1996,335:1001-1009.
  • 8[8]Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Survival Study (4S). Lancet,1994,344:1383-1389.
  • 9[9]Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Eng J Med,1998,339:1349-1357.
  • 10[10]MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.Lancet,2002,360(9326):7-22.

共引文献71

同被引文献32

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部